Literature DB >> 6309392

Inhibition of dopamine-activated adenylate cyclase and dopamine binding by opiate receptors in rat striatum.

S Gentleman, M Parenti, N H Neff, C B Pert.   

Abstract

Low-affinity (micromolar) 3H-dopamine binding was measured under conditions which permitted dopamine activation and opiate inhibition of adenylate cyclase in rat striatal membranes. Opiate drugs and peptides inhibited the dopamine binding in the presence of both GTP and Gpp(NH)p. Opiate inhibition of adenylate cyclase was, however, observed only in the presence of GTP. It is suggested that the dopamine D1 receptor in striatum may be modulated by the opiate delta receptor through a shared guanine nucleotide binding subunit.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309392     DOI: 10.1007/bf00734995

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  28 in total

1.  Slowly reversible binding of catecholamine to a nucleotide-sensitive state of the beta-adrenergic receptor.

Authors:  L T Williams; R J Lefkowitz
Journal:  J Biol Chem       Date:  1977-10-25       Impact factor: 5.157

2.  Coupling of opiate receptors to adenylate cyclase: requirement for Na+ and GTP.

Authors:  A J Blume; D Lichtshtein; G Boone
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

3.  Muscarinic cholinergic receptor modulation of beta-adrenergic receptor affinity for catecholamines.

Authors:  A M Watanabe; M M McConnaughey; R A Strawbridge; J W Fleming; L R Jones; H R Besch
Journal:  J Biol Chem       Date:  1978-07-25       Impact factor: 5.157

4.  Ascorbate destruction of opiate stereospecific binding in guinea pig brain homogenate.

Authors:  C E Dunlap; F M Leslie; M Rado; B M Cox
Journal:  Mol Pharmacol       Date:  1979-07       Impact factor: 4.436

5.  Morphine-like drugs inhibit the stimulation of E prostaglandins of cyclic AMP formation by rat brain homogenate.

Authors:  H O Collier; A C Roy
Journal:  Nature       Date:  1974-03-01       Impact factor: 49.962

6.  Guanine nucleotides distinguish between two dopamine receptors.

Authors:  I Creese; T Usdin; S H Snyder
Journal:  Nature       Date:  1979-04-05       Impact factor: 49.962

7.  The role of hormone receptors and GTP-regulatory proteins in membrane transduction.

Authors:  M Rodbell
Journal:  Nature       Date:  1980-03-06       Impact factor: 49.962

8.  Interactions of divalent cations and guanine nucleotides at alpha 2-noradrenergic receptor binding sites in bovine brain mechanisms.

Authors:  D C U'Prichard; S H Snyder
Journal:  J Neurochem       Date:  1980-02       Impact factor: 5.372

9.  The fat cell adenylate cyclase system. Characterization and manipulation of its bimodal regulation by GTP.

Authors:  D M Cooper; W Schlegel; M C Lin; M Rodbell
Journal:  J Biol Chem       Date:  1979-09-25       Impact factor: 5.157

10.  Demonstration and characterization of opiate inhibition of the striatal adenylate cyclase.

Authors:  P Y Law; J Wu; J E Koehler; H H Loh
Journal:  J Neurochem       Date:  1981-05       Impact factor: 5.372

View more
  2 in total

1.  Dopamine depletion augments endogenous opioid-induced locomotion in the nucleus accumbens using both mu 1 and delta opioid receptors.

Authors:  L Churchill; B P Roques; P W Kalivas
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

2.  The Opioid Interactions of the Antipsychotic Medications Risperidone and Amisulpride in Mice and Their Potential Use in the Treatment of Other Non-Psychotic Medical Conditions.

Authors:  Shaul Schreiber; Chaim G Pick
Journal:  Cell Mol Neurobiol       Date:  2020-11-13       Impact factor: 5.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.